National Pro-Life Group Praises Ruling Suspending FDA’s ‘Rubber Stamp’ of Abortion Drug as Democrat-Led States Stockpile Pills

One of the nation’s leading pro-life organizations is praising the ruling out of a U.S. district court in Texas Friday that has stayed the Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone nationwide.

However, within hours of the ruling by Judge Matthew Kacsmaryk, a Donald Trump appointee, a Washington State federal judge then issued a decision in State of Washington v. United States Food and Drug Administration, which blocked “altering the status quo and rights as it relates to the availability of Mifepristone.”

Read More

Texas Case Could End Access to ‘Dangerous’ Abortion-Inducing Drug Nationwide

A federal judge heard oral arguments Wednesday in a lawsuit that could end availability of abortion-inducing drug mifepristone throughout the nation.

The case was brought against the Food and Drug Administration (FDA) in November by Alliance for Hippocratic Medicine, a coalition of pro-life OB/GYNS, pediatricians, and other Christian healthcare providers, who are seeking a preliminary injunction to require the FDA to either withdraw or suspend its approval of the drug while the lawsuit continues.

Read More

Republican Attorneys General Warn CVS and Walgreens Against Mailing and Distributing Abortion-Inducing Drugs

Missouri Attorney General Andrew Bailey led 19 other Republican state attorneys general (AGs) in a warning letter to CVS and Walgreens that asserts federal law forbids using the mail to send or receive drugs that are intended to be used to produce an abortion.

Bailey and the coalition of attorneys general wrote to the two drugstore chains, informing them that their announced plan to use the mail to distribute abortion pills is both unsafe and illegal.

Read More

Wall Street Journal Rips Vaccine Makers: ‘Designed Studies to Get the Results They Wanted’

Wall Street Journal (WSJ) editorial board member Allysia Finley took to task both the federal government and the pharmaceutical giants profiting from the sale of their COVID mRNA booster shots for a “deceptive advertising” push for Americans to continue taking boosters without proof of their safety or effectiveness. The U.S. Department of Health and Human Services (HHS) and its health and regulatory agencies are engaged in a “deceptive advertising” campaign, wrote Finley Sunday, suggesting the pressure tactics “shouldn’t come as a surprise,” since the federal government “took the unprecedented step of ordering vaccine makers to produce them and recommending them without data supporting their safety or efficacy.”

Read More

FDA Approves Chemical Abortion Pills to Be Sold at Retail Pharmacies

The Food and Drug Administration (FDA) made a regulatory change that allows independent and chain drugstores, as well as mail-order companies, to offer a drug that induces abortion, making it easier for women and girls to conduct their own abortions at home or in college dorms.

The New York Times reported Tuesday evening the FDA’s regulatory change, which apparently came without an official announcement to the public, officially removes the requirement for the patient to have an in-person doctor’s visit for the prescription of mifepristone, the first drug used to induce an abortion.

Read More

Doctors Allege Corruption and Mismanagement of COVID Pandemic Leaving Americans at High Risk for Vaccine Injury and Death

Doctors and scientists who participated in Wisconsin Senator Ron Johnson’s (R) COVID-19 roundtable Wednesday shared their personal experiences of the federal government’s alleged corruption and mismanagement of the COVID-19 pandemic that they say have likely caused many more examples of serious vaccine injury for which Americans have no recourse.

Read More

Report: FDA Concerned Providers Prescribing Abortion-Inducing Drugs for Women Who Are Not Pregnant

The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.

“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”

Read More